Opportunity

Mississippi Procurement Portal #3140004752

Mississippi Public Health Laboratory seeks five-year NAAT platform and reagent rental

Posted

November 16, 2026

Respond By

December 07, 2026

Identifier

3140004752

NAICS

325413, 334516

The Mississippi State Department of Health is seeking a five-year reagent-rental package for public health laboratory NAAT testing. - Buyer: Mississippi State Department of Health, Mississippi State Public Health Laboratory (MPHL), Purchasing Department. - OEMs and vendors: No manufacturers, OEMs, or vendors are named in the solicitation. - Requested products: Annual estimated volumes are 73,000 CT/GC combination tests, 10,000 Trichomonas vaginalis tests, 100 HIV NAAT tests, and 100 HCV NAAT tests. Also requested are specimen collection kits, one NAAT platform, and one UPS battery backup/surge protector. No part numbers are specified. - Platform requirements: The system must be new, fully automated, and use FDA-approved NAAT assays. Its menu must include CT/GC, Trichomonas, HIV, HCV, and an FDA- or EUA-approved SARS-CoV-2 assay. Required features include random access, automated pipetting, on-board reagent storage, and specimen tracking; refurbished, previously owned, and demonstration equipment is unacceptable. - Services and integration: The five-year agreement includes platform use, maintenance, technical service, delivery, installation, and training, with applicable costs included in reagent and kit pricing. The system must interface bi-directionally with MPHL’s EPIC Beaker LIMS, and be installed and ready for use within four weeks of award. - Verification and closeout: The vendor must supply materials to verify CT/GC and Trichomonas performance on at least 100 specimens each, and HIV and HCV performance on at least 100 specimens each, before patient results are reported. Vendor removal of the instrument at contract end is at no cost to MPHL.

Description

The Mississippi State Public Health Laboratory seeks quotes for a five-year reagent rental agreement covering reagents and kits for testing Chlamydia trachomatis, Trichomonas vaginalis, Neisseria gonorrhoeae, HCV NAAT, and HIV NAAT. The agreement includes the test platform and its maintenance in the reagent and kit pricing. The platform must be new, fully automated, and use an FDA-approved NAAT assay; refurbished, previously owned, or demonstration equipment is not acceptable. Quotes will be used to establish a competitive starting price for a reverse auction.

View original listing